Indian Pharmaceutical Company Recalls Anti-seizure and Hypertension Drugs from US Market

by Shirley Johanna on  June 30, 2015 at 11:39 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Hyderabad-based Dr Reddy's Laboratories has recalled some drugs from the US market that are used to treat hypertension and seizure.
Indian Pharmaceutical Company Recalls Anti-seizure and Hypertension Drugs from US Market
Indian Pharmaceutical Company Recalls Anti-seizure and Hypertension Drugs from US Market

The firm started recalling the tablets because Divalproex Sodium extended-release tablets has failed dissolution tests and Amlodipine Besylate and Atorvastatin Calcium tablets are close to expiry time.

According to USFDA, the firm has recalled Divalproex Sodium extended-release tablets, USP, 250 mg of 100 count (7,479 units) and 500 count bottles (2,544) units on the ground of failed dissolution specifications, exceeded specification at the 9-hour time point.

The drug which is used to treat epilepsy is recalled under the "class-II" classification.

Amlodipine Besylate and Atorvastatin Calcium tablets are used to treat high blood pressure (hypertension) or chest pain (angina) are recalled under "class III" classification.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

High Blood Pressure Drug Toxicity Diet Lifestyle and Heart Disease Diet and High Blood Pressure Stress and the Gender Divide Silent Killer Diseases Quiz on Hypertension Can Garlic Control High Blood Pressure High Blood Pressure and Herbs Benefits of Blood Pressure Tablets on your Health 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...